A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Zentera Therapeutics HK Limited
- Target Recruit Count
- 8
- Registration Number
- NCT05127811
- Locations
- 🇨🇳
BeiJing Cancer Hospital, BeiJing, Beijing, China
🇨🇳Fudan University Shanghai Cancer Hospital, Shanghai, Shanghai, China
🇨🇳Sun Yan Set University Cancer Center, Guangzhou, Guangdong, China
A Phase 1b Study of ZN-c3 in Chinese Subjects
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Zentera Therapeutics HK Limited
- Target Recruit Count
- 38
- Registration Number
- NCT04972422
- Locations
- 🇨🇳
Fudan University Zhongshan Hospital, Shanghai, Shanghai, China
🇨🇳Sichuan University Huaxi Hospital, Chengdu, Sichuan, China
🇨🇳Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Zentera Therapeutics HK Limited
- Target Recruit Count
- 12
- Registration Number
- NCT04852419
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath